Cargando…
FOXO1 overexpression and loss of pSerine256-FOXO1 expression predicts clinical outcome in esophageal adenocarcinomas
The function of Forkhead box O 1 (FOXO1) and pSerine256-FOXO1 immunostaining in esophageal cancer is unclear. To clarify the prognostic role of nuclear FOXO1 and cytoplasmic pSerine256-FOXO1 immunostaining, a tissue microarray containing more than 600 esophageal cancers was analyzed. In non-neoplast...
Autores principales: | Grupp, Katharina, Uzunoglu, Faik Güntac, Melling, Nathaniel, Hofmann, Bianca, El Gammal, Alexander Tarek, Grotelüschen, Rainer, Heumann, Asmus, Bellon, Eugen, Reeh, Matthias, Wolters-Eisfeld, Gerrit, Ghabdan, Tarik, Nentwich, Michael, Bachmann, Kai, Bockhorn, Maximillian, Bogoevski, Dean, Izbicki, Jakob Robert, Kutup, Asad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255784/ https://www.ncbi.nlm.nih.gov/pubmed/30478420 http://dx.doi.org/10.1038/s41598-018-35459-4 |
Ejemplares similares
-
Reduced RBM3 expression is associated with aggressive tumor features in esophageal cancer but not significantly linked to patient outcome
por: Grupp, Katharina, et al.
Publicado: (2018) -
Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma
por: Reeh, Matthias, et al.
Publicado: (2017) -
Decentralized colorectal cancer care in Germany over the last decade is associated with high in-hospital morbidity and mortality
por: Ghadban, Tarik, et al.
Publicado: (2019) -
The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer
por: Reeh, Matthias, et al.
Publicado: (2016) -
CD147 expression lacks prognostic relevance in esophageal cancer
por: Küsters, Natalie, et al.
Publicado: (2022)